ESC Premium Access

Circulating transforming growth factor-beta1 and progression of the mitral valve prolapse: fifteen-year follow-up

Congress Session

About the speaker

Professor Eduard Malev

Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)
0 follower

4 more presentations in this session

Trends in incidence and mortality from non-rheumatic degenerative mitral valve disease across europe, over the past three decades.

Speaker: Doctor B. Al-khayatt (London, GB)

Thumbnail

The MIDA Quantitative mortality risk score: prognostic model in floppy mitral valves

Speaker: Doctor B. Essayagh (Rochester, US)

Thumbnail

Myocardial efficiency in severe asymptomatic primary mitral regurgitation: relation to quantitative measures of regurgitation

Speaker: Professor J. Sorensen (Uppsala, SE)

Thumbnail

Clinical and haemodynamic effects of percutaneous edge-to-edge mitral valve repair in atrial versus ventricular functional mitral regurgitation

Speaker: Professor M. Claeys (Antwerp, BE)

Thumbnail

Access the full session

A deep dive into mitral regurgitation

Speakers: Professor E. Malev, Doctor B. Al-khayatt, Doctor B. Essayagh, Professor J. Sorensen, Professor M. Claeys
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: case presentation.

27 August 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

ESC Premium Access

Congenital isolated bilateral upper pulmonary veins atresia - oligosymptomatic adult patient case report.

27 August 2021

This platform is supported by

logo Novo Nordisk